The company’s market cap is set at $1.39 billion. Market analysts have given MedAssets a consensus rating of “hold” for this week, according to the report.
The stock’s one-year high is $25.57, and its one-year low is $17.
More articles on finance issues:
CMS pitches bundled payment approach for hip, knee replacements
10 things for CFOs to know about CAUTIs
RCM tip of the day: Streamlined systems interactions
